Oncology Medical News about osteosarcoma cells;proliferation inhibition effect;docetaxel combined with cisplatin

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Proliferation inhibition effect of docetaxel combined with cisplatin on osteosarcoma cells
Medical Oncology, 06/08/09

Jin W et al. - In a trial to examine the proliferation inhibition effect of combined use of docetaxel and cisplatin on osteosarcoma cells, it was concluded that the combined use of docetaxel and cisplatin is more effective than either of the drugs used alone in inhibiting the proliferation of osteosarcoma cells.

Methods

The effects of docetaxel and cisplatin used alone and combined on osteosarcoma cell line HOS8603 were examined by means of cell count, morphologic observation, and flow cytometry (FCM).

Results

Docetaxel and cisplatin either used alone or in combination, significantly inhibited the proliferation of osteosarcoma cells and apparently induced the apoptosis.
The effect of the combined drugs was better than that of the drugs used alone.

<< Previous
Dysregulation of heat shock protein 27 expression in oral tongue...

Next >>
Positive expression of ERCC1 predicts a poorer platinum-based...